Close Menu

Lung Cancer

News and reporting on lung cancer.

NEW YORK (GenomeWeb News) – The National Heart, Lung, and Blood Institute wants to see more pulmonary researchers applying 'omics data and genomics-based knowledge to lung disease studies, and plans to fund a new program to train young investigators in using such approaches.

Cepheid Launches Standardized Xpert BCR-ABL Monitor Test
Cepheid has released an updated version of its Xpert BCR-ABL Monitor test, which now incorporates "lot-specific standardization" based on World Health Organization BCR-ABL guidelines.

Rosetta Genomics has published data validating its miRview Lung assay as a means to differentiate between the four main types of lung cancer.

Tegal, a publicly held company previously involved in the application of semiconductor and microelectromechanical systems technology, is shifting its strategic focus to the genomic medicine space by merging with healthcare information technology firm CollabRx.

NEW YORK (GenomeWeb News) – Rosetta Genomics on Monday filed a preliminary prospectus with the US Securities and Exchange Commission for a public offering of common stock aimed at raising up to $35 million.

NEW YORK (GenomeWeb News) – Kreatech Diagnostics and Oridis Biomarkers today said that they will co-develop and commercialize DNA-FISH assays for oncology applications.

Clinical proteomics firm Expression Pathology has changed its name to OncoPlex Diagnostics and opened a CLIA laboratory in Rockville, Md.

NEW YORK (GenomeWeb News) – Insight Genetics and Kindstar Globalgene Technology announced Thursday evening a licensing deal for the Insight ALK Screen lung cancer test.

NEW YORK (GenomeWeb News) – Clarient Diagnostic Services today said that it has licensed worldwide rights from Insight Genetics to intellectual property covering the anaplastic lymphoma kinase biomarker.

NEW YORK (GenomeWeb News) – In spite of increased access to genetic testing, such tests do not drive up use of healthcare, according to a study published today in the early online edition of Genetics in Medicine.

Pages

Retraction Watch writes that a cancer researcher has had an eighth paper retracted.

Computational biologist James Taylor has died, according to Johns Hopkins University.

The Centers for Disease Control and Prevention is starting to test people for SARS-CoV-2 antibodies, according to the New York Times.

In PLOS this week: features of tumor-infiltrating immune cells, regulatory effects of SNPs associated with prostate cancer risk, and more.